T-cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down ...

UCLA's AlloESO-T cell therapy targets solid tumors at an estimated $5,000 per dose — a fraction of current costs — but remains in preclinical mouse trials only.

UCLA researchers developed ready-made cancer-fighting T cells from cord blood stem cells that can attack solid tumors through ...

The gray portion of this schematic represents a nanodisc, where for the first time researchers were able to replicate the native membrane environment (red dots) of a T-cell receptor (cyan). One of the ...

Immunotherapies strengthen the body's own anticancer defenses in a highly targeted manner. In therapies using so-called CAR T ...

Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before. This breakthrough may help explain why immunotherapy works for some ...

Blocking a tumor antioxidant restored T cell activity and made some resistant cancers more responsive to immunotherapy in ...

T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can't easily distinguish cancerous T cells from ...

UCLA researchers have developed a way to mass-produce cancer-fighting T cells from blood stem cells found in cord blood, ...